EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

SNHG18 deficiency reprograms arginine metabolism to foster an immunosuppressive microenvironment in prostate cancer bone metastasis

Zhong Xie, Shaojie Li, Jie Yang, Zhengpeng Zhang, Shuren Li, Chuandong Lang, Mingxing Yang, Bin Wang, Xiaowei Yu, Zhihong Li, Yijun Kang, Chi Yin und 1 weitere

Cancer Letters · 2026-04 · 644 · 218326

DOI: 10.1016/j.canlet.2026.218326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-04. Verfasst von Zhong Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, The Second XiangYa Hospital, Central South University, Changsha, Hunan, 410011, China; National Clinical Research Center…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Bone Neoplasms, Arginine, RNA, Long Noncoding. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced prostate cancer (PCa) frequently metastasizes to bone, where the immunosuppressive tumor microenvironment (TME) limits immune checkpoint blockade (ICB) efficacy. Nevertheless, the molecular mechanisms underlying this immunosuppressive bone TME and bone metastasis (BM) are not yet fully understood. Analysis of clinical PCa samples, employing in situ hybridization, RT-qPCR, and bioinformatics, demonstrated a progressive downregulation of lncRNA SNHG18 throughout PCa progression, with the lowest expression levels observed in BM associated with poor prognosis. We demonstrate that the downregulation of SNHG18 contributes to castration-resistant prostate cancer (CRPC) and BM development by utilizing an androgen-independent Myc-CaP subline, derived from Androgen receptor positive (AR+) Myc-CaP cells through chronic steroid deprivation, alongside in vitro and in vivo models. SNHG18 alters the bone microenvironment through the reprogramming of arginine metabolism. Deficiency of SNHG18 resulted in the upregulation of ARG2 and NOS2, which caused arginine depletion, enhanced infiltration of immunosuppressive cells, and compromised effector T-cell function. Mechanistically, SNHG18 bound to YBX1 and recruited TRIM21 to induce YBX1 degradation, thereby inhibiting YBX1-mediated transcriptional activation of NOS2 and ARG2. Therapeutically, SNHG18 overexpression enhanced anti-PD-1 therapy efficacy in murine BM models. Consequently, SNHG18 deficiency fosters an immunosuppressive TME and promotes PCa BM. SNHG18 expression may serve as a predictive biomarker for ICB response, offering a novel strategy to overcome immunotherapy resistance in PCa BM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentBone NeoplasmsArginineRNA, Long NoncodingProstatic Neoplasms, Castration-ResistantProstatic NeoplasmsMaleHumansAnimalsMiceGene Expression Regulation, NeoplasticCell Line, Tumor

Substanzen

ArginineRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Spine Surgery, The Second XiangYa Hospital, Central South University, Changsha, Hunan, 410011, China; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic…
  • Department of Surgical Oncology, The First People's Hospital of Xiangtan City, University of South China, Xiangtan, Hunan, 411100, China.
  • Department of Urology Surgery, The First People's Hospital of Xiangtan City, University of South China, Xiangtan, Hunan, 411100, China.
  • Department of Orthopedic Surgery, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, 230001, China.
  • Department of Orthopedic Surgery, The First People's Hospital of Xiangtan City, University of South China, Xiangtan, Hunan, 411100, China.
  • Cancer Research Center, The First People's Hospital of Xiangtan City, University of South China, Xiangtan, Hunan, 411100, China.

Förderung

  • National Natural Science Foundation of China
  • Hunan Provincial Natural Science Foundation

Zitieren

APA

Xie, Z., Li, S., Yang, J., Zhang, Z., Li, S., Lang, C., Yang, M., Wang, B., Yu, X., Li, Z., Kang, Y., Yin, C., & Yang, Q. (2026). SNHG18 deficiency reprograms arginine metabolism to foster an immunosuppressive microenvironment in prostate cancer bone metastasis. Cancer Letters, 644, 218326. https://doi.org/10.1016/j.canlet.2026.218326

Vancouver

Xie Z, Li S, Yang J, Zhang Z, Li S, Lang C, et al. SNHG18 deficiency reprograms arginine metabolism to foster an immunosuppressive microenvironment in prostate cancer bone metastasis. Cancer Letters. 2026;644:218326. doi:10.1016/j.canlet.2026.218326

BibTeX
@article{Xie2026,
  author = {Xie, Zhong and Li, Shaojie and Yang, Jie and Zhang, Zhengpeng and Li, Shuren and Lang, Chuandong and Yang, Mingxing and Wang, Bin and Yu, Xiaowei and Li, Zhihong and Kang, Yijun and Yin, Chi and Yang, Qing},
  title = {SNHG18 deficiency reprograms arginine metabolism to foster an immunosuppressive microenvironment in prostate cancer bone metastasis},
  journal = {Cancer Letters},
  year = {2026},
  volume = {644},
  pages = {218326},
  doi = {10.1016/j.canlet.2026.218326}
}
Kostenlos starten →